Pharmacokinetic aspects of biotechnology products
- 1 September 2004
- journal article
- review article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 93 (9) , 2184-2204
- https://doi.org/10.1002/jps.20125
Abstract
No abstract availableKeywords
This publication has 118 references indexed in Scilit:
- The further evolution of biotechNature Reviews Drug Discovery, 2003
- Pharmacokinetics and Pharmacodynamics of Tenecteplase in Fibrinolytic Therapy of Acute Myocardial InfarctionClinical Pharmacokinetics, 2002
- A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalitiesThe Journal of Pediatrics, 2001
- Pharmacokinetic Studies with Recombinant CytokinesClinical Pharmacokinetics, 1997
- Problems of Delivery of Monoclonal AntibodiesClinical Pharmacokinetics, 1995
- Effects of Route and Formulation on Clinical Pharmacokinetics of Interleukin-2Clinical Pharmacokinetics, 1994
- Clinical Pharmacokinetics of OctreotideClinical Pharmacokinetics, 1993
- Atrial Natriuretic PeptideClinical Pharmacokinetics, 1993
- The Role of Pharmacokinetics in the Development of Biotechnologically Derived AgentsClinical Pharmacokinetics, 1992
- Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1982